Skip to Content

Cardiff Oncology Inc CRDF

Morningstar Rating
$1.68 −0.02 (1.18%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CRDF is trading at a 68% discount.
Price
$1.66
Fair Value
$8.85
Uncertainty
Extreme
1-Star Price
$92.45
5-Star Price
$8.14
Economic Moat
Bnc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CRDF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.70
Day Range
$1.661.73
52-Week Range
$0.942.79
Bid/Ask
$1.60 / $1.74
Market Cap
$75.06 Mil
Volume/Avg
86,137 / 166,836

Key Statistics

Price/Earnings (Normalized)
Price/Sales
168.85
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
26

Comparables

Valuation

Metric
CRDF
CLDX
TYRA
Price/Earnings (Normalized)
Price/Book Value
1.006.953.72
Price/Sales
168.85392.22
Price/Cash Flow
Price/Earnings
CRDF
CLDX
TYRA

Financial Strength

Metric
CRDF
CLDX
TYRA
Quick Ratio
9.048.4621.25
Current Ratio
9.308.8422.14
Interest Coverage
Quick Ratio
CRDF
CLDX
TYRA

Profitability

Metric
CRDF
CLDX
TYRA
Return on Assets (Normalized)
−33.99%−31.80%−18.26%
Return on Equity (Normalized)
−37.66%−34.51%−19.01%
Return on Invested Capital (Normalized)
−40.53%−34.11%−22.76%
Return on Assets
CRDF
CLDX
TYRA
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRWwmr$537.7 Bil
VRTX
Vertex Pharmaceuticals IncWwvwfc$108.4 Bil
REGN
Regeneron Pharmaceuticals IncTffsft$104.6 Bil
MRNA
Moderna IncDws$33.4 Bil
ARGX
argenx SE ADRSsvlm$23.7 Bil
BNTX
BioNTech SE ADRCfksm$22.0 Bil
ALNY
Alnylam Pharmaceuticals IncYlzkyc$19.5 Bil
BMRN
Biomarin Pharmaceutical IncGvdmjnw$16.7 Bil
RPRX
Royalty Pharma PLC Class AQpdddk$14.0 Bil
INCY
Incyte CorpWfjvvrj$13.5 Bil

Sponsor Center